ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05340	Primary immunodeficiency	3/23	30/7206	0.000109033210643
ko05321	Inflammatory bowel disease (IBD)	3/23	56/7206	0.000705204931077
ko00120	Primary bile acid biosynthesis	2/23	20/7206	0.00178808184118
ko04610	Complement and coagulation cascades	3/23	79/7206	0.00191779793407
ko04060	Cytokine-cytokine receptor interaction	4/23	191/7206	0.00285248857266
ko04620	Toll-like receptor signaling pathway	3/23	100/7206	0.00375399554054
ko00983	Drug metabolism - other enzymes	2/23	42/7206	0.00776473111712
ko00633	Nitrotoluene degradation	1/23	3/7206	0.00954614455981
ko05204	Chemical carcinogenesis	2/23	48/7206	0.0100552855701
ko00232	Caffeine metabolism	1/23	5/7206	0.0158617477506
ko00600	Sphingolipid metabolism	2/23	63/7206	0.0169126809355
ko05134	Legionellosis	2/23	74/7206	0.0228997790293
ko05130	Pathogenic Escherichia coli infection	2/23	77/7206	0.0246645782404
ko00460	Cyanoamino acid metabolism	1/23	11/7206	0.0345782676421
ko04064	NF-kappa B signaling pathway	2/23	96/7206	0.0370605434894
ko05132	Salmonella infection	2/23	98/7206	0.0384812220814
ko00430	Taurine and hypotaurine metabolism	1/23	14/7206	0.0438083697879